Mesoblast (MESO) Share-based Compensation (2016 - 2023)

Mesoblast (MESO) reported Share-based Compensation of -$791000.0 for Q1 2023, up 58.13% on a YoY basis from -$500234.0 in Q1 2022, and up 43.78% sequentially from -$1.4 million in Q4 2022.

Mesoblast (MESO) Share-based Compensation (2016 - 2023) Analysis & Trends

Mesoblast (MESO) has 8 years of Share-based Compensation data on file, last reported at -$791000.0 in Q1 2023.

  • For the quarter ending Q1 2023, Share-based Compensation rose 58.13% year-over-year to -$791000.0; the trailing twelve-month figure through Mar 2023 stood at -$1.5 million (down 107.87% YoY), and the FY2022 full-year result was $5.5 million, down 55.75% from the prior year.
  • Share-based Compensation climbed to -$791000.0 in Q1 2023, from -$1.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $23.0 million in Q2 2021 to a low of -$4.9 million in Q3 2020.
  • A 5-year average of $2.2 million and a median of -$1.1 million in 2021 frame the typical range for Share-based Compensation.
  • Peak annual rise in Share-based Compensation reached 909.62% in 2020, while the deepest fall reached 507.09% in 2020.
  • Tracing MESO's Share-based Compensation over 5 years: stood at -$1.6 million in 2019, then soared by 909.62% to $13.3 million in 2020, then tumbled by 111.13% to -$1.5 million in 2021, then climbed by 4.93% to -$1.4 million in 2022, then soared by 43.78% to -$791000.0 in 2023.
  • Business Quant data shows MESO's Share-based Compensation at -$791000.0 in Q1 2023, -$1.4 million in Q4 2022, and -$350000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6.39 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 3.20 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9.26 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 87.30 Mn
10 Mesoblast 19.81 Bn 19.68 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 -791,000.00
Mar 31, 2023 -791,000.00
Dec 31, 2022 -1.41 Mn
Dec 31, 2022 -1.41 Mn
Sep 30, 2022 -350,000.00
Sep 30, 2022 -350,000.00
Jun 30, 2022 1.09 Mn
Jun 30, 2022 1.09 Mn
Mar 31, 2022 -1.89 Mn
Mar 31, 2022 -1.89 Mn
Dec 31, 2021 -1.48 Mn
Dec 31, 2021 -1.48 Mn
Sep 30, 2021 -1.08 Mn
Sep 30, 2021 -1.08 Mn
Jun 30, 2021 22.95 Mn
Jun 30, 2021 22.95 Mn
Mar 31, 2021 -2.02 Mn
Mar 31, 2021 -2.02 Mn
Dec 31, 2020 13.30 Mn
Dec 31, 2020 13.30 Mn